title: Pharmacokinetics and pharmacodynamics of gliclazide from immediate and modified release formulation tablets in rats.
abstract: The objective of the study was to compare pharmacokinetic and pharmacodynamic parameters of gliclazide after administration of immediate (IR) and modified release (MR) tablets. The experiment included rats with both normoglycemia and streptozocin (STZ)-induced hyperglycemia. Several MR formulations were designed and in-vitro drug release profile was assessed by a dissolution test. For the further in-vivo study the most suitable formulation was chosen. For pharmacokinetic analysis concentrations of gliclazide in plasma were determined by a validated high performance liquid chromatography (HPLC) method with UV detection. Pharmacodynamic efficacy of the drug was evaluated by measuring blood glucose concentrations. Gliclazide bioavailability was totally different for two formulations in both healthy and diabetic rats based on area under the curve (AUC), time to peak concentration (tmax) and peak concentration (Cmax). Reduction of blood glucose level was significantly higher after the administration of IR than MR formulation. The highest pharmacodynamic efficacy of gliclazide was observed in the normal animals group after administration of the IR tablets, while hypoglycemic effect of the drug was diminished in animals with induced diabetes. Our study suggested that results of reduction in blood glucose level for STZ-induced groups were not comparable with pharmacodynamic effect for normal group. It may be assumed that a decrease in glycemia in healthy subjects might not be a suitable factor for characterizing anti-diabetic drugs.
authors.affiliation: Department of Physical Pharmacy and Pharmacokinetics, K. Marcinkowski University of Medical Sciences, Poland.
authors.forename: M
authors.initials: M
authors.lastname: Resztak
authors.affiliation: Department of Physical Pharmacy and Pharmacokinetics, K. Marcinkowski University of Medical Sciences, Poland.
authors.forename: Tw
authors.initials: T
authors.lastname: Hermann
authors.affiliation: Department of Pharmaceutical Technology, Medical University of Gdańsk, Poland.
authors.forename: W
authors.initials: W
authors.lastname: Sawicki
authors.affiliation: Department of Physical Pharmacy and Pharmacokinetics, K. Marcinkowski University of Medical Sciences, Poland.
authors.forename: Dz
authors.initials: Dz
authors.lastname: Danielak
keywords: Gliclazide; HPLC; Immediate release; In-vitro; Modified release; Pharmacokinetics; in-vivo correlation
references.citation: J Pharm Pharmacol. 2007 Jul;59(7):971-6
references.pmid: 17637192
references.citation: Metabolism. 2003 Aug;52(8 Suppl 1):29-34
references.pmid: 12939737
references.citation: J Pharm Pharm Sci. 2006;9(2):169-89
references.pmid: 16959187
references.citation: Clin Exp Pharmacol Physiol. 2006 Jan-Feb;33(1-2):17-26
references.pmid: 16445694
references.citation: J Pharm Pharm Sci. 2003 May-Aug;6(2):282-91
references.pmid: 12935440
references.citation: AAPS PharmSciTech. 2006 Jan 03;7(1):E1
references.pmid: 16584139
references.citation: Pak J Pharm Sci. 2002 Jan;15(1):63-70
references.pmid: 16414869
references.citation: Diabete Metab. 1989 Mar-Apr;15(2):61-75
references.pmid: 2525491
references.citation: Br J Clin Pharmacol. 2000 Mar;49(3):223-30
references.pmid: 10718777
references.citation: J Pharm Sci. 2001 Aug;90(8):1176-85
references.pmid: 11536222
references.citation: Biopharm Drug Dispos. 2007 Jul;28(5):241-8
references.pmid: 17415747
references.citation: Med Sci Monit. 2005 Jun;11(6):BR181-188
references.pmid: 15917713
references.citation: Drugs. 1993 Jul;46(1):92-125
references.pmid: 7691511
references.citation: Diabetes Care. 2004 May;27(5):1047-53
references.pmid: 15111519
references.citation: Diabetes Res Clin Pract. 1991;14 Suppl 2:S65-7
references.pmid: 1794268
references.citation: Drugs. 2002;62(9):1357-64; discussion 1365-6
references.pmid: 12076188
references.citation: Pharm Res. 1993 Jul;10(7):1066-70
references.pmid: 8378249
references.citation: Biomaterials. 2004 Jul;25(15):3041-8
references.pmid: 14967537